Detroit Clinical Research Center

Detroit, Michigan 48377

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Hormone Receptor Positive Malignant Neoplasm of Breast, Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Pancreatic Cancer

Studies at this site

• A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies. — Withdrawn before enrolling
• PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score — Completed
• OctavaPink for Women With Dense Breast After Negative Mammography — Status unconfirmed